SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Valentis (VLTS)
An SI Board Since April 1999
Posts SubjectMarks Bans Symbol
81 15 0 VLTS
Emcee:  Mike McFarland Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
81Valentis and Schering A.G. Enter Multi-Product Collaboration BURLINGAME, Calif.nigel bates-12/20/2002
80Valentis Extends Tender Offer to October 15, 2002 BURLINGAME, Calif., Aug. 30 SemiBull-9/2/2002
79Valentis Receives Nasdaq Delisting Notice and Plans Appeal BURLINGAME, Calif.,SemiBull-8/27/2002
78Mike, I am presently only tracking VLTS. Consequently, I tend to assume your pSemiBull-7/14/2002
77Semi--do you have any opinion on all this, I bog down when I read this stuff, inMike McFarland-7/11/2002
76Valentis Extends Tender Offer to September 3, 2002 BURLINGAME, Calif., July 3 /SemiBull-7/4/2002
75Valentis Announces Extension of Tender Offer to July 8, 2002 BURLINGAME, Calif.SemiBull-6/5/2002
74Westfield rates Valentis "speculative buy" NEW YORK, June 4 (Reuters)SemiBull-6/4/2002
73Valentis Announces the Issuance of Two Broad Patents BURLINGAME, Calif., May 28SemiBull-5/28/2002
72Valentis Licenses GeneSwitch(R) Gene Regulation Technology to Medigene A.G. BURSemiBull-5/20/2002
71Valentis Announces Offer to Purchase for Cash Its Series a Preferred Stock BURLSemiBull-5/12/2002
70Valentis Announces Third Quarter Fiscal 2002 Financial Results BURLINGAME, CaliSemiBull-5/12/2002
69Valentis Announces Issuance of Pegylated Liposomes Patent in Europe, Initiation SemiBull-4/24/2002
68>>BURLINGAME, Calif., Jan. 15 /PRNewswire-FirstCall/ -- Valentis, Inc. (Natuck-1/15/2002
67Valentis Enters Cross License Agreement With Genzyme BURLINGAME, Calif., Jan. 9SemiBull-1/9/2002
66psbiofund.com SAB is not given, but found this: Dr. Marc E. Lippman serves as Mike McFarland-12/28/2001
65Thu 5:43pm VLTS Perseus-Soros fund takes 5 pct stake in Valentis - Reuters Securgao seng-12/27/2001
64Sure hope they have a portfolio of therapies undergoing differing stages of FDA SemiBull-12/3/2001
63Ouch for shareholders: >>BURLINGAME, Calif., Dec 3, 2001 /PRNewswire via tuck-12/3/2001
62Valentis Licenses Electroporation Technology From Genetronics BURLINGAME, Calif.SemiBull-11/29/2001
61>>BURLINGAME, Calif., Nov. 14 /PRNewswire/ -- Valentis, Inc. (Nasdaq: VLTStuck-11/14/2001
60>>BURLINGAME, Calif., Aug. 1 /PRNewswire/ -- Valentis, Inc. (Nasdaq: VLTS tuck-8/1/2001
59*chit chat *OT* Well, I don't anymore own shares of Valentis. messages.yahoMike McFarland-7/6/2001
58Missed this abstract --ASGT No. 464 Adenovirus Vectors Modified with PolyethylMike McFarland-6/21/2001
57ViraMASC (I'm getting awfully forgetful, so just catching up on some filingMike McFarland-6/21/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News